
Today's News
CNS (Neurologics [MS])
FDA Grants Priority Review to Cladribine Tablets for the Treatment of Relapsing Forms of Multiple Sclerosis
from PharmaLive - July 28, 2010
Gastroinestinals (Incontinence)
Antares Pharma Announces Positive Top Line Results From Its Pivotal Phase 3 Study of Anturol Gel for the Treatment of Overactive Bladder
from PharmaLive - July 28, 2010
Hormones (Blood Modifiers)
Medicare Rules Threaten Epogen with 38% Drop
from FiercePharma - July 28, 2010
Now Available
In Time for Your Business Plan
A quick assessment when you
need it the most.
Published reports
Physicians' Awareness, Attitudes, and Usage of E-Sampling Programs
Interim Summary Report of PCP Response
Email for more information
PPI Risk of Fracture and IMPACT Assessement Study
Email for more information
IMPACT Assessment Study: The FDA Review of LABAs and LABA Containing Products - The Physician Perspective (Wave 1 & 2)
Email for more information
Preparing for Loss of Patent in 2010/2011: An Analysis of Promotional Materials
Email for more information
Coming Soon
CD Promo Message View Tracking on Fanapt, Invega Sustenna, Seroquel XR and Saphris (Wave 2)
Email for more information
Multi-Channel Marketing Preferences,
The Physician Perspective
Email for more information
IMPACT Assessment Study: The FDA Review of LABAs and LABA Containing Products - The Physician Perspective (Wave 3)
Email for more information